Algen Biotechnologies and AstraZeneca Partner to Accelerate Immunology Drug Discovery Using AI and CRISPR Read more
Boehringer’s HERNEXEOS Approved in China as First Oral Targeted Therapy for HER2-Mutant Advanced NSCLC Read more